19-7647699-T-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006949.4(STXBP2):​c.1697-26T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.63 in 1,612,724 control chromosomes in the GnomAD database, including 323,632 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.67 ( 34672 hom., cov: 30)
Exomes 𝑓: 0.63 ( 288960 hom. )

Consequence

STXBP2
NM_006949.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -4.33
Variant links:
Genes affected
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
This place is a probable branch point but likely benign (scored 1 / 10). Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 19-7647699-T-G is Benign according to our data. Variant chr19-7647699-T-G is described in ClinVar as [Benign]. Clinvar id is 260102.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.805 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
STXBP2NM_006949.4 linkuse as main transcriptc.1697-26T>G intron_variant ENST00000221283.10 NP_008880.2 Q15833-1Q53GF4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
STXBP2ENST00000221283.10 linkuse as main transcriptc.1697-26T>G intron_variant 1 NM_006949.4 ENSP00000221283.4 Q15833-1

Frequencies

GnomAD3 genomes
AF:
0.670
AC:
101634
AN:
151690
Hom.:
34624
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.762
Gnomad AMI
AF:
0.691
Gnomad AMR
AF:
0.674
Gnomad ASJ
AF:
0.505
Gnomad EAS
AF:
0.827
Gnomad SAS
AF:
0.506
Gnomad FIN
AF:
0.735
Gnomad MID
AF:
0.500
Gnomad NFE
AF:
0.612
Gnomad OTH
AF:
0.647
GnomAD3 exomes
AF:
0.635
AC:
158882
AN:
250264
Hom.:
51529
AF XY:
0.623
AC XY:
84260
AN XY:
135324
show subpopulations
Gnomad AFR exome
AF:
0.767
Gnomad AMR exome
AF:
0.649
Gnomad ASJ exome
AF:
0.509
Gnomad EAS exome
AF:
0.820
Gnomad SAS exome
AF:
0.494
Gnomad FIN exome
AF:
0.728
Gnomad NFE exome
AF:
0.613
Gnomad OTH exome
AF:
0.634
GnomAD4 exome
AF:
0.625
AC:
913664
AN:
1460916
Hom.:
288960
Cov.:
41
AF XY:
0.621
AC XY:
451021
AN XY:
726734
show subpopulations
Gnomad4 AFR exome
AF:
0.774
Gnomad4 AMR exome
AF:
0.656
Gnomad4 ASJ exome
AF:
0.508
Gnomad4 EAS exome
AF:
0.853
Gnomad4 SAS exome
AF:
0.492
Gnomad4 FIN exome
AF:
0.722
Gnomad4 NFE exome
AF:
0.620
Gnomad4 OTH exome
AF:
0.633
GnomAD4 genome
AF:
0.670
AC:
101744
AN:
151808
Hom.:
34672
Cov.:
30
AF XY:
0.674
AC XY:
49970
AN XY:
74166
show subpopulations
Gnomad4 AFR
AF:
0.763
Gnomad4 AMR
AF:
0.674
Gnomad4 ASJ
AF:
0.505
Gnomad4 EAS
AF:
0.826
Gnomad4 SAS
AF:
0.506
Gnomad4 FIN
AF:
0.735
Gnomad4 NFE
AF:
0.612
Gnomad4 OTH
AF:
0.649
Alfa
AF:
0.554
Hom.:
3128
Bravo
AF:
0.677

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanNov 12, 2023This variant is classified as Benign based on local population frequency. This variant was detected in 89% of patients studied by a panel of primary immunodeficiencies. Number of patients: 85. Only high quality variants are reported. -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxNov 12, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Familial hemophagocytic lymphohistiocytosis 5 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.054
DANN
Benign
0.35
BranchPoint Hunter
1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs794073; hg19: chr19-7712585; API